Approved Study Database
| Ref. No. | Scientific Title | Principal investigator |
|---|---|---|
| 2019.646 | Regulation of Peritoneal Transport by the Cyclooxygenase Pathway and Its Pharmacological Modulation |
Prof. SZETO Cheuk Chun 司徒卓俊 |
| 2018.271 | A Phase 2 Study to Evaluate the Safety and Effect on Proteinuria of OMS721 in Subjects with IgA Nephropathy, Lupus Nephritis, Membranous Nephropathy, or C3 Glomerulopathy including Dense Deposit Disease |
Prof. SZETO Cheuk Chun 司徒卓俊 |
| 2018.245 | Defining the Optimal Duration of Treatment for “Low-Risk” Peritoneal Dialysis-Related Peritonitis |
Prof. SZETO Cheuk Chun 司徒卓俊 |
| 2020.601 | Optimization of Urine Processing for Biomarker Development of Kidney Diseases |
Prof. SZETO Cheuk Chun 司徒卓俊 |
| 2020.643 | The Efficacy and Safety of SGLT2 Therapy in Advanced Diabetic Kidney Disease |
Prof. SZETO Cheuk Chun 司徒卓俊 |
| 2020.224 | Optimal Strategy for the Monitoring of Dialysis Adequacy in Peritoneal Dialysis Patients |
Prof. SZETO Cheuk Chun 司徒卓俊 |
| 2018.333 | A Randomized, Multicenter, Double-Blind, Parallel-Group, Active-Control Study of the Efficacy and Safety of Sparsentan for the Treatment of Immunoglobulin A Nephropathy |
Prof SZETO Cheuk Chun 司徒卓俊 |
| 2019.363 | Intra-renal miR-21 expression in IgA nephropathy |
Prof. SZETO Cheuk Chun 司徒卓俊 |
| 2009.007 | The Prevalence and Prognostic Implication of Malnutrition in Chinese Peritoneal Dialysis Patients | Prof. Szeto Cheuk-Chun |
| 2009.009 | Urinary Micro-RNA Level ini Patients with Lupus Nephritis | Prof. Szeto Cheuk-Chun |
| 2008.057 | Reversal of Endotoxaemia and Vascular Dysfunction by Physiological Dialysis Solution in Diabetic Peritoneal Dialysis Patients | Dr. Szeto Cheuk-chun |
| 2009.057 | The Safety and Short-Term Efficacy of Aliskiren in the Treatment of Immunoglobulin A Nephropathy | Prof. Szeto Cheuk-Chun |
| 2012.554 | A study to compare the “Ergomotor” Intervention Program to conventional physiotherapy treatment in managing work-related neck-shoulder disorders: A randomized controlled trial | Dr SZETO Pui Yuk Grace |
| 2024.503 | Identification of OCT-based imaging biomarkers for predicting treatment response of refractory diabetic macular edema to faricimab and dexamethasone implant. A real-world prospective study | Dr. SZETO Simon Ka Ho |
| 2016.448 | To understand the attitudes of the patients receiving palliative care, their relatives and health professionals towards using Traditional Chinese Medicine treatment in Hong Kong Palliative care. |
Miss TAI Pui Hei 戴沛希 |
| 2009.327 | Drug attitude of psychiatric patients and their relatives before and after a psychoeducation talk | Dr. Tai Wing Ki |
| 2011.299 | The Capacity of Everyday Decision Making in Patients with Schizophrenia | Dr Tai Wing Ki |
| 2011.300 | Would Change in Subjective Perception of Illness Affect Duration of Acute Hospitalization in Chinese Patients with Schizophrenia? | Dr Tai Wing Ki |
| 2020.213 | Exploring the relationship between oral health and quality of life among people with schizophrenia spectrum disorder in Tai Po district community | Ms. TAI Yik Shan |
| 2009.357 | Non-Invasive Optical Biopsy in Cervical Specimens by Using Nonlinear Optical Microscopy: A Preliminary and Feasibility Study | Dr. Tak-Hong Cheung |
| 2021.170 | Randomised controlled trial of awake transnasal laser-assisted surgery (TNLS) and microlaryngeal surgery for benign laryngeal lesions | Dr. TAM Aurora Ka Yue |
| 2022.649 | Intracranial nasofrontal dermoid cyst and a hair in the nose tip without a sinus tract identified |
Dr. TAM Aurora Ka Yue 譚嘉裕 |
| 2023.644 | Randomized controlled trial of awake transnasal laser-assisted surgery (TNLS) and microlaryngeal surgery for vocal cord cyst | Dr. TAM Aurora Ka Yue |
| 2024.499 | Epidemiology and Impact of Human Papillomavirus (HPV) Vaccine on Recurrent respiratory papillomatosis - a Hong Kong review | Dr. TAM Aurora Ka Yue |
| 2022.123 | Case report of multisystemic smooth muscle dysfunction syndrome (MSMDS) in Hong Kong | Dr Tam Catherine Wing Yan |
| 2009.632 | Walking balance of patients with ankle sprain after rehabilitations Vs normal people: A comparative study | Tam Choi Chi |
| 2023.560 | Clinical utility of lipoprotein(a) and its related polygenic risk score in risk stratification of cardiovascular complications among Chinese patients with type 2 diabetes |
Dr. TAM Claudia Ha Ting 譚夏亭 |
| 2017.681 | Early growth genetics and cardiometabolic risk in Chinese adolescents |
Dr. TAM Claudia Ha Ting 譚夏亭 |
| 2017.224 | Predicting excess hospital burden using temperature forecasts | Prof. TAM Greta Chun Huen |
| 2015.718 | Opt-out HIV testing in out-patient setting | Prof. TAM Greta Chun Huen |
| 2023.290 | Type 2 Diabetes Distress Assessment System and Acceptance and Action Diabetes Questionnaire: Validation of questionnaires in Chinese Population | Dr. TAM Hon Lon |
| 2023.498 | A mhealth social support program on health behaviors among people at risk of metabolic syndrome: a feasibility randomized controlled trial |
Dr. TAM Hon Lon 譚漢麟 |
| 2023.010 | A resource-oriented educational program on health behaviors among people at risk of metabolic syndrome | Dr. TAM Hon Lon |
| 2024.563 | Co-design of child-initiated healthy lifestyles for parents: a pilot study |
Dr. TAM Hon Lon Hon Lon Tam |
| 2024.363 | Nurse-led acceptance-based healthy lifestyles program for community-dwelling patients with pneumoconiosis: A waitlist pilot randomized controlled trial |
Dr. TAM Hon Lon 譚漢麟 |
| 2024.185 | Outcomes of Transnasal Endoscopic Repair of Spontaneous Anterior Skull Base Cerebrospinal Fluid Leak - a Hong Kong Tertiary Center Review | Dr. TAM Ka Yue Aurora |
| 2006.089 | 磁貼穴位與傳統毫針針刺療法對改善骨性膝關節炎的臨床研究 | TAM Lai Sha Lisa |
| 2010.491 | Effect of early intensive treatment in patients with recent-onset rheumatoid arthritis | Prof. TAM Lai Shan |
| 2014.167 | Exploiting the immunomodulatory and anti-inflammatory role of IL35 to modulate inflammation and autoreactive B cell activation in rheumatoid arthritis | Prof. TAM Lai Shan |
| 2012.200 | A Phase 2, Randomized Study to Evaluate the Efficacy and Safety of MEDI-546 in Subjects with Systemic Lupus Erythematosus | Prof. TAM Lai Shan |
| 2008.161 | SERAPHIN-OL: Study with An ERA in Pulmonary Arterial Hypertension to Improve Clinical Outcome (Open Label) – Long-term Single-arm Open-label Extension Study of the SERAPHIN study, to Assess the Safety and Tolerability of ACT-064922 in Patients with Symptomatic Pulmonary Arterial Hypertension | Prof. TAM Lai Shan |
| 2008.160 | SERAPHIN: Study with Endothelin Receptor Antagonist in Pulmonary Arterial Hypertension to Improve Clinical Outcome | Prof Tam Lai Shan |
| 2008.159 | A Phase IIb, Multi-center, Open-label, Follow-up Study to Assess the Safety and Efficacy of Epratuzumab in Serologically-Positive Systemic Lupus Erythematosus Patients with Active Disease Who Participated in Study SL0007 | Asso. Prof. TAM Lai Shan |
| 2012.007 | A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Tolerability of BIIB023 in Subjects With Lupus Nephritis | Prof. TAM Lai Shan |
| 2014.082 | A Dose-Blinded, 2-Dose Level, Parallel-Group, Multicenter, Long Term Extension Study to Evaluate the Long-Term Safety, Efficacy, and Immunogenicity of BIIB023 in Subjects with Lupus Nephritis | Prof. TAM Lai Shan |
| 2011.378 | A Phase 3, Multicenter, Open-Label, Extension Study to Assess the Safety and Tolerability of Epratuzumab Treatment in Systemic Lupus Erythematosus Subjects (EMBODY 4) | Prof. TAM Lai Shan |
| 2012.476 | Alteration in bone density and microstructure in early rheumatoid arthritis and its relationship with bone erosion: A one-year study by HR-pQCT and MRI | Prof. TAM Lai Shan |
| 2010.056 | Effect of anti-TNF | Professor TAM LAI SHAN |
| 2013.568 | A 48 weeks, phase II, randomized, double-blind, placebo-controlled, proof of concept and dose finding study of three different dose regimens of BI 655066 administered subcutaneously in patients with ankylosing spondylitis. | Prof. TAM Lai Shan |
| 2013.470 | A multi-center, uncontrolled extension study evaluating efficacy and safety of SAR153191 on top of DMARDs in patients with active Rheumatoid Arthritis (RA) | Prof Tam Lai Shan |
Page 199 of 262.